Posterior reversible encephalopathy syndrome during ipilimumab therapy for malignant melanoma.

[1]  R. Kefford,et al.  Resolution of severe ipilimumab-induced hepatitis after antithymocyte globulin therapy. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  R. Hamilton,et al.  Posterior reversible encephalopathy syndrome (PRES) with immune system activation, VEGF up-regulation, and cerebral amyloid angiopathy. , 2011, Journal of computer assisted tomography.

[3]  D. Schadendorf,et al.  Improved survival with ipilimumab in patients with metastatic melanoma. , 2010, The New England journal of medicine.

[4]  D. Kallmes,et al.  Posterior reversible encephalopathy syndrome: associated clinical and radiologic findings. , 2010, Mayo Clinic proceedings.

[5]  J. Baizabal-Carvallo,et al.  Posterior reversible encephalopathy syndrome as a complication of acute lupus activity , 2009, Clinical Neurology and Neurosurgery.

[6]  Kwang Ki Kim,et al.  A case of gemcitabine and cisplatin associated posterior reversible encephalopathy syndrome. , 2009, Cancer research and treatment : official journal of Korean Cancer Association.

[7]  E. Small,et al.  Anti-cytotoxic T-lymphocyte antigen-4 antibody: the first in an emerging class of immunomodulatory antibodies for cancer treatment. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  P. Sharma,et al.  CTLA-4 blockade increases IFNγ-producing CD4+ICOShi cells to shift the ratio of effector to regulatory T cells in cancer patients , 2008, Proceedings of the National Academy of Sciences.

[9]  K. Kimura,et al.  A case of autoimmune thyroid disease presenting posterior reversible encephalopathy syndrome , 2008, Journal of the Neurological Sciences.

[10]  Geraldo B. Silva,et al.  Posterior reversible encephalopathy syndrome (PRES) induced by cyclosporine use in a patient with collapsing focal glomeruloesclerosis , 2008, International Urology and Nephrology.

[11]  R. Cumurciuc,et al.  Posterior reversible encephalopathy syndrome during sunitinib therapy. , 2008, Revue neurologique.

[12]  W. Bartynski.  Posterior Reversible Encephalopathy Syndrome, Part 1: Fundamental Imaging and Clinical Features , 2008, American Journal of Neuroradiology.

[13]  S. Rosenberg,et al.  Ipilimumab (Anti-CTLA4 Antibody) Causes Regression of Metastatic Renal Cell Cancer Associated With Enteritis and Hypophysitis , 2007, Journal of immunotherapy.

[14]  J. K. Smith,et al.  Dexamethasone-induced posterior reversible encephalopathy syndrome. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  R. Goldberg,et al.  A case of oxaliplatin-related posterior reversible encephalopathy syndrome. , 2007, Clinical colorectal cancer.

[16]  J. Boardman,et al.  Posterior reversible encephalopathy syndrome in infection, sepsis, and shock. , 2006, AJNR. American journal of neuroradiology.

[17]  D. Couriel,et al.  Tacrolimus‐associated posterior reversible encephalopathy syndrome after allogeneic haematopoietic stem cell transplantation , 2003, British journal of haematology.

[18]  J. Port,et al.  Reversible intracerebral pathologic entities mediated by vascular autoregulatory dysfunction. , 1998, Radiographics : a review publication of the Radiological Society of North America, Inc.

[19]  G. Sobue,et al.  Cisplatin neurotoxicity presenting as reversible posterior leukoencephalopathy syndrome. , 1998, AJNR. American journal of neuroradiology.

[20]  L R Caplan,et al.  A reversible posterior leukoencephalopathy syndrome. , 1996, The New England journal of medicine.

[21]  R. Schwartz,et al.  Hypertensive encephalopathy: findings on CT, MR imaging, and SPECT imaging in 14 cases. , 1992, AJR. American journal of roentgenology.

[22]  R. Weiss,et al.  Cytarabine and neurologic toxicity. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  B. Siesjö,et al.  Physiological role of cerebrovascular sympathetic nerves in the autoregulation of cerebral blood flow , 1976, Brain Research.